Abstract PS11-03: Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: A subgroup analysis of germline <i>BRCA1</i> or <i>BRCA2</i> mutations from the phase 3 BROCADE3 trial

Authors: Hans Wildiers, Jean-Pierre Ayoub, Michael Friedlander, Bella Kaufman, Banu K. Arun, Hyo S. Han, Shannon L. Puhalla, David Maag, Dai Feng, Christine K. Ratajczak, Bruce A. Bach, Véronique Diéras

Published: 2021-02-15

DOI: 10.1158/1538-7445.sabcs20-ps11-03

Source: Full article